84 related articles for article (PubMed ID: 26146093)
1. The possibility of using magnetic nanoparticles to increase the therapeutic efficiency of Herceptin antibody.
Rasaneh S; Dadras MR
Biomed Tech (Berl); 2015 Oct; 60(5):485-90. PubMed ID: 26146093
[TBL] [Abstract][Full Text] [Related]
2. Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery.
Zhou Z; Badkas A; Stevenson M; Lee JY; Leung YK
Int J Pharm; 2015 Jun; 487(1-2):81-90. PubMed ID: 25865568
[TBL] [Abstract][Full Text] [Related]
3. Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with
Cędrowska E; Pruszyński M; Gawęda W; Żuk M; Krysiński P; Bruchertseifer F; Morgenstern A; Karageorgou MA; Bouziotis P; Bilewicz A
Molecules; 2020 Feb; 25(5):. PubMed ID: 32106568
[TBL] [Abstract][Full Text] [Related]
4. Specific drug delivery efficiently induced human breast tumor regression using a lipoplex by non-covalent association with anti-tumor antibodies.
Lin YL; Tsai NM; Chen CH; Liu YK; Lee CJ; Chan YL; Wang YS; Chang YC; Lin CH; Huang TH; Wang CC; Chi KH; Liao KW
J Nanobiotechnology; 2019 Feb; 17(1):25. PubMed ID: 30728015
[TBL] [Abstract][Full Text] [Related]
5. Trastuzumab-conjugated liposome-coated fluorescent magnetic nanoparticles to target breast cancer.
Jang M; Yoon YI; Kwon YS; Yoon TJ; Lee HJ; Hwang SI; Yun BL; Kim SM
Korean J Radiol; 2014; 15(4):411-22. PubMed ID: 25053899
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of magnetic nanoparticles coated by 5-fluorouracil imprinted polymer for controlled drug delivery in mouse breast cancer model.
Hashemi-Moghaddam H; Kazemi-Bagsangani S; Jamili M; Zavareh S
Int J Pharm; 2016 Jan; 497(1-2):228-38. PubMed ID: 26621688
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
Elbialy NS; Fathy MM; Khalil WM
Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
[TBL] [Abstract][Full Text] [Related]
8. Artemisinin loaded chitosan magnetic nanoparticles for the efficient targeting to the breast cancer.
Natesan S; Ponnusamy C; Sugumaran A; Chelladurai S; Shanmugam Palaniappan S; Palanichamy R
Int J Biol Macromol; 2017 Nov; 104(Pt B):1853-1859. PubMed ID: 28359890
[TBL] [Abstract][Full Text] [Related]
9. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
Yu K; Zhao J; Zhang Z; Gao Y; Zhou Y; Teng L; Li Y
Int J Pharm; 2016 Jan; 497(1-2):78-87. PubMed ID: 26617314
[TBL] [Abstract][Full Text] [Related]
10. Magnetic nanobubbles with potential for targeted drug delivery and trimodal imaging in breast cancer: an in vitro study.
Song W; Luo Y; Zhao Y; Liu X; Zhao J; Luo J; Zhang Q; Ran H; Wang Z; Guo D
Nanomedicine (Lond); 2017 May; 12(9):991-1009. PubMed ID: 28327075
[TBL] [Abstract][Full Text] [Related]
11. Magnetic nanoparticles for magnetic drug targeting.
Lyer S; Singh R; Tietze R; Alexiou C
Biomed Tech (Berl); 2015 Oct; 60(5):465-75. PubMed ID: 26351783
[TBL] [Abstract][Full Text] [Related]
12. Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer.
Gunduz U; Keskin T; Tansık G; Mutlu P; Yalcin S; Unsoy G; Yakar A; Khodadust R; Gunduz G
Biomed Pharmacother; 2014 Jul; 68(6):729-36. PubMed ID: 25194441
[TBL] [Abstract][Full Text] [Related]
13. A new application of plant virus nanoparticles as drug delivery in breast cancer.
Esfandiari N; Arzanani MK; Soleimani M; Kohi-Habibi M; Svendsen WE
Tumour Biol; 2016 Jan; 37(1):1229-36. PubMed ID: 26286831
[TBL] [Abstract][Full Text] [Related]
14. Reducible polyamidoamine-magnetic iron oxide self-assembled nanoparticles for doxorubicin delivery.
Chen J; Shi M; Liu P; Ko A; Zhong W; Liao W; Xing MM
Biomaterials; 2014 Jan; 35(4):1240-8. PubMed ID: 24239110
[TBL] [Abstract][Full Text] [Related]
15. Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer.
Grifantini R; Taranta M; Gherardini L; Naldi I; Parri M; Grandi A; Giannetti A; Tombelli S; Lucarini G; Ricotti L; Campagnoli S; De Camilli E; Pelosi G; Baldini F; Menciassi A; Viale G; Pileri P; Cinti C
J Control Release; 2018 Jun; 280():76-86. PubMed ID: 29733876
[TBL] [Abstract][Full Text] [Related]
16. Functionalized nanoscale β-1,3-glucan to improve Her2+ breast cancer therapy: In vitro and in vivo study.
Nasrollahi Z; Mohammadi SR; Mollarazi E; Yadegari MH; Hassan ZM; Talaei F; Dinarvand R; Akbari H; Atyabi F
J Control Release; 2015 Mar; 202():49-56. PubMed ID: 25597638
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers.
Jiang Q; Hao S; Xiao X; Yao J; Ou B; Zhao Z; Liu F; Pan X; Luo B; Zhi H
Breast Cancer; 2016 May; 23(3):445-55. PubMed ID: 25691133
[TBL] [Abstract][Full Text] [Related]
18. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
19. Polymeric nanocarriers for magnetic targeted drug delivery: preparation, characterization, and in vitro and in vivo evaluation.
Licciardi M; Scialabba C; Fiorica C; Cavallaro G; Cassata G; Giammona G
Mol Pharm; 2013 Dec; 10(12):4397-407. PubMed ID: 24168360
[TBL] [Abstract][Full Text] [Related]
20. Herceptin-functionalized pure paclitaxel nanocrystals for enhanced delivery to HER2-postive breast cancer cells.
Noh JK; Naeem M; Cao J; Lee EH; Kim MS; Jung Y; Yoo JW
Int J Pharm; 2016 Nov; 513(1-2):543-553. PubMed ID: 27686050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
